Découvrir nos portefeuilles : Investisseur PEA |  International |  Trader
Accès Membre / Client

Accueil Zonebourse  >  Actions  >  Xetra  >  Carl Zeiss Meditec AG    AFX   DE0005313704

SynthèseCotationsGraphiquesActualitésAnalysesAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
Métier
Logo Carl Zeiss Meditec AG
Provides integrated medical technology

Carl Zeiss Meditec AG is an integrated medical technology company.

It operates in two main business areas: Ophthalmology and Microsurgery.

The Ophthalmology offers complete solutions for treating the four main eye ailments: vision defects, cataract, glaucoma and retinal disorders.

The Ophthalmic equipment and systems offered by the company handle the diagnosis, progress monitoring, treatment and follow-up treatment of different ophthalmic syndromes.

The Microsurgery offers surgical microscopes and visualization solutions for ear, nose and throat surgery or neurosurgery.

The products are mainly used as support equipment for the removal of tumours as well as the treatment of vascular diseases and functional disorders.

Carl Zeiss Meditec was founded on July 4, 2002 and is headquartered in Jena, Germany.

Nombre d'employés : 2 942 personnes.
Ventes par activité
201220132014
EUR (en Millions)%EUR (en Millions)%EUR (en Millions)%
Microsurgery378,2343.9%394,1843.5%390,3842.9%
Ophthalmic Systems375,9143.6%390,9543.1%372,8941%
Surgical Ophthalmology107,7412.5%121,3113.4%145,9816.1%
Ventes par région
201220132014
EUR (en Millions)%EUR (en Millions)%EUR (en Millions)%
Germany366,1142.5%397,6843.9%425,2746.8%
United States284,0933%300,0033.1%276,2130.4%
Japan120,0013.9%113,7012.5%101,5911.2%
Europe (excluding Germany)91,6710.6%95,0610.5%106,1911.7%
Rest of World------
Dirigeants
Nom AgeDepuisTitre
Ludwin Monz PhD, MBA512000Chairman-Management Board, President & CEO
Michael Kaschke, PhD572002Chairman-Supervisory Board
Christian Müller, PhD472009Chief Financial Officer
Markus Guthoff, PhD-2004Vice Chairman-Supervisory Board
Cornelia Grandy-2011Member-Supervisory Board
Jörg Heinrich-2011Member-Supervisory Board
Thomas Spitzenpfeil522011Member-Supervisory Board
Jann Gerrit Ohlendorf--Director-Corporate Communications
Thomas Simmerer522011Member-Management Board
Sebastian Frericks-2013Director-Investor Relations
Actionnaires
Nom Actions%
Carl-Zeiss-Stiftung 52 893 270 65,1%
Oddo Asset Management SA 2 469 819 3,04%
OppenheimerFunds, Inc. 1 707 566 2,10%
Norges Bank Investment Management 1 275 379 1,57%
Financière de l'Échiquier SA 714 900 0,88%
ING Investment Management Advisors BV 643 322 0,79%
Montanaro Asset Management Ltd. 600 000 0,74%
Manning & Napier Advisors LLC 382 120 0,47%
Baillie Gifford & Co. 373 345 0,46%
Fourton Fund Management Co. Ltd. 337 485 0,42%
Secteur
Santé
Services de santé
 Equipements et fournitures en soins de santé
  Equipement et technologie médicale avancés
   Equipement et technologie médicale de pointe - NCA
Publicité
Secteur Equipement et technologie médicale avancés
CroissanceRentabilité
THERMO FISHER SCI..
FRESENIUS SE & CO..
ILLUMINA, INC.
PHILIPS
CERNER CORPORATIO..
BOSTON SCIENTIFIC..
INTUITIVE SURGICA..
EDWARDS LIFESCIEN..
OLYMPUS CORP
WATERS CORPORATIO..
VARIAN MEDICAL SY..
HOLOGIC, INC.
RESMED INC.
RESMED INC. (CHES..
SIRONA DENTAL SYS..
PERKINELMER, INC.
CEPHEID
GN STORE NORD A/S
ELEKTA PUBL AB
ALERE INC
Secteur Equipement et technologie médicale avancés
© 2015 Factset   
Rechercher
Contactez-nous
+33 (0)4 78 30 41 42
Rejoignez
123 033 membres
Cotations dynamiques  
ON
| OFF